Literature DB >> 11689562

The mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor.

Malcolm Lyon1, Jon A Deakin, John T Gallagher.   

Abstract

Hepatocyte growth factor/scatter factor, in addition to binding to its specific signal-transducing receptor, Met, also interacts with both heparan and dermatan sulfates with high affinity. We have investigated the comparative role of these two glycosaminoglycans in the activation of Met by hepatocyte growth factor/scatter factor. Using glycosaminoglycan-deficient CHO pgsA-745 cells we have shown that growth factor activity is critically dependent upon glycosaminoglycans, and that heparan sulfate and dermatan sulfate are equally potent as co-receptors. Cross-linked 1:1 conjugates of growth factor and either heparan or dermatan sulfate do not dimerize under physiological conditions and are biologically active. This implies that a ternary signaling complex with Met forms in vivo. Native Met isolated from CHO pgsA-745 cells shows only very weak intrinsic affinity for heparin in vitro. Also, a heparin-derived hexasaccharide, which is the minimal size for high affinity binding to the growth factor alone, is sufficient to induce biological activity. Together these observations imply that the role of these glycosaminoglycan may be primarily to effect a conformational change in hepatocyte growth factor/scatter factor, rather than to induce a necessary growth factor dimerization, or to stabilize a ternary complex by additionally interacting with Met.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689562     DOI: 10.1074/jbc.M107506200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor.

Authors:  Ermanno Gherardi; Mark E Youles; Ricardo N Miguel; Tom L Blundell; Luisa Iamele; Julian Gough; Abhishek Bandyopadhyay; Guido Hartmann; P Jonathan G Butler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-03       Impact factor: 11.205

2.  Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

Authors:  Yuji Kashiwakura; Kenji Tamayose; Kazuhisa Iwabuchi; Yukihiko Hirai; Takashi Shimada; Kunio Matsumoto; Toshikazu Nakamura; Masami Watanabe; Kazuo Oshimi; Hiroyuki Daida
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  The regulatory role of heparin on c-Met signaling in hepatocellular carcinoma cells.

Authors:  Evin İşcan; Aysim Güneş; Peyda Korhan; Yeliz Yılmaz; Esra Erdal; Neşe Atabey
Journal:  J Cell Commun Signal       Date:  2016-12-14       Impact factor: 5.782

4.  Multistage Tandem Mass Spectrometry of Chondroitin Sulfate and Dermatan Sulfate.

Authors:  Alicia M Bielik; Joseph Zaia
Journal:  Int J Mass Spectrom       Date:  2011-08-15       Impact factor: 1.986

5.  Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling.

Authors:  Fabiola Cecchi; Deborah Pajalunga; C Andrew Fowler; Aykut Uren; Daniel C Rabe; Benedetta Peruzzi; Nicholas J Macdonald; Davida K Blackman; Stephen J Stahl; R Andrew Byrd; Donald P Bottaro
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

6.  Analysis of Glycosaminoglycans Using Mass Spectrometry.

Authors:  Gregory O Staples; Joseph Zaia
Journal:  Curr Proteomics       Date:  2011       Impact factor: 0.837

7.  A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms.

Authors:  May Joy C Miller; Catherine E Costello; Anders Malmström; Joseph Zaia
Journal:  Glycobiology       Date:  2006-02-17       Impact factor: 4.313

Review 8.  Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.

Authors:  Khushboo Gulati; Krishna Mohan Poluri
Journal:  Glycoconj J       Date:  2015-12-03       Impact factor: 2.916

9.  Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.

Authors:  Evin Ozen; Aysim Gozukizil; Esra Erdal; Aykut Uren; Donald P Bottaro; Nese Atabey
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

10.  Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.

Authors:  Maryse Delehedde; Lucie Devenyns; Claude-Alain Maurage; Romain R Vivès
Journal:  Int J Cell Biol       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.